Literature DB >> 17688939

Prosthetic vascular grafts: wrong models, wrong questions and no healing.

Peter Zilla1, Deon Bezuidenhout, Paul Human.   

Abstract

In humans, prosthetic vascular grafts remain largely without an endothelium, even after decades of implantation. While this shortcoming does not affect the clinical performance of large bore prostheses in aortic or iliac position, it contributes significantly to the high failure rate of small- to medium-sized grafts (SMGs). For decades intensive but largely futile research efforts have been under way to address this issue. In spite of the abundance of previous studies, a broad analysis of biological events dominating the incorporation of vascular grafts was hitherto lacking. By focusing on the three main contemporary graft types, expanded polytetrafluoroethylene (ePTFE), Dacron and Polyurethane (PU), accumulated clinical and experimental experience of almost half a century was available. The main outcome of this broad analysis-supported by our own experience in a senescent non-human primate model-was twofold: Firstly, inappropriate animal models, which addressed scientific questions that missed the point of clinical relevance, were largely used. This led to a situation where the vast majority of investigators unintentionally studied transanastomotic rather than transmural or blood-borne endothelialization. Given the fact that in patients transanastomotic endothelialization (TAE) covers only the immediate perianastomotic region of sometimes very long prostheses, TAE is rather irrelevant in the clinical context. Secondly, transmural endothelialization seems to have a time window of opportunity before a build-up of an adverse microenvironment. In selecting animal models that prematurely terminate this build-up through the early presence of an endothelium, the most significant 'impairment factor' for physiological tissue regeneration in vascular grafts remained ignored. By providing insight into mechanisms and experimental designs which obscured the purpose and scope of several decades of vascular graft studies, future research may better address clinical relevance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17688939     DOI: 10.1016/j.biomaterials.2007.07.017

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  116 in total

1.  Immediate use of an arteriovenous prosthetic graft for life-saving dialysis in a child.

Authors:  Chiara Grimaldi; Alessandro Crocoli; Lara De Galasso; Stefano Picca; Gian Luigi Natali; Jean De Ville De Goyet
Journal:  Pediatr Nephrol       Date:  2012-07-10       Impact factor: 3.714

2.  Fabricating mechanically improved silk-based vascular grafts by solution control of the gel-spinning process.

Authors:  Maria Rodriguez; Jonathan A Kluge; Daniel Smoot; Matthew A Kluge; Daniel F Schmidt; Christopher R Paetsch; Peter S Kim; David L Kaplan
Journal:  Biomaterials       Date:  2019-10-23       Impact factor: 12.479

3.  Animal models of cardiovascular disease as test beds of bioengineered vascular grafts.

Authors:  Sindhu Row; Daniel D Swartz; Stelios T Andreadis
Journal:  Drug Discov Today Dis Models       Date:  2018-06-18

4.  Tissue-engineered vascular graft remodeling in a growing lamb model: expression of matrix metalloproteinases.

Authors:  Ian Cummings; Sarah George; Jens Kelm; Doerthe Schmidt; Maximilian Y Emmert; Benedikt Weber; Gregor Zünd; Simon P Hoerstrup
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

Review 5.  Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia.

Authors:  Chengyi Tu; Subhamoy Das; Aaron B Baker; Janeta Zoldan; Laura J Suggs
Journal:  ACS Nano       Date:  2015-04-10       Impact factor: 15.881

6.  Inhibiting intimal hyperplasia in prosthetic vascular grafts via immobilized all-trans retinoic acid.

Authors:  Elaine K Gregory; Antonio Webb; Janet M Vercammen; Megan E Kelly; Banu Akar; Robert van Lith; Edward M Bahnson; Wulin Jiang; Guillermo A Ameer; Melina R Kibbe
Journal:  J Control Release       Date:  2018-01-31       Impact factor: 9.776

7.  The performance of cross-linked acellular arterial scaffolds as vascular grafts; pre-clinical testing in direct and isolation loop circulatory models.

Authors:  Timothy Pennel; George Fercana; Deon Bezuidenhout; Agneta Simionescu; Ting-Hsien Chuang; Peter Zilla; Dan Simionescu
Journal:  Biomaterials       Date:  2014-05-09       Impact factor: 12.479

8.  Fibro-porous poliglecaprone/polycaprolactone conduits: synergistic effect of composition and in vitro degradation on mechanical properties.

Authors:  Harsh N Patel; Roman Garcia; Carrie Schindler; Derrick Dean; Steven M Pogwizd; Raj Singh; Yogesh K Vohra; Vinoy Thomas
Journal:  Polym Int       Date:  2015-04       Impact factor: 2.990

9.  Improved recellularization of ex vivo vascular scaffolds using directed transport gradients to modulate ECM remodeling.

Authors:  Zehra Tosun; Peter S McFetridge
Journal:  Biotechnol Bioeng       Date:  2013-04-29       Impact factor: 4.530

10.  Cell response to RGD density in cross-linked artificial extracellular matrix protein films.

Authors:  Julie C Liu; David A Tirrell
Journal:  Biomacromolecules       Date:  2008-10-01       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.